The efficacy of cariprazine in chronic schizophrenia – post hoc analyses of phase II/III clinical trials
Introduction Chronic schizophrenia patients are experiencing persistent and severe illness for more than 15-20 years and are usually suffering from long-term negative symptoms. Cariprazine, a novel D3-D2 partial agonist has been proven to be effective in the treatment of acute schizophrenia, howeve...
Kaydedildi:
| Asıl Yazarlar: | , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Cambridge University Press
2022-06-01
|
| Seri Bilgileri: | European Psychiatry |
| Konular: | |
| Online Erişim: | https://www.cambridge.org/core/product/identifier/S0924933822008227/type/journal_article |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|